Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-β-cyclodextrin

International Journal of Clinical Pharmacology and Therapeutics

Volumn 39, Issue 1, 2001, Pages 33-36

  Bannwarth, B ^a   Bertin, P ^a   Pehourcq F ^a   Schaeverbeke, T ^a   Gillet, P ^a   Lefrancois G ^a   Treves R ^a   Dehais, J ^a   Netter, P ^a   Gaucher, A ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Nonsteroidal anti inflammatory drug; Pharmacokinetics; Piroxicam; Synovial fluid

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM BETA CYCLODEXTRIN;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG SYNOVIAL FLUID LEVEL; ENZYME INHIBITION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MICROENCAPSULATION; RHEUMATIC DISEASE; SAMPLING;

EID: 0035153857     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP39033     Document Type: Article

References (15)

1. Rapid oral absorption profile of piroxicam from its β-cyclodextrin complex
2. Where are peripheral analgesics acting?
3. Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid
4. Pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid
5. A reproducible and rapid HPLC assay for quantitation of piroxicam in plasma
6. β-cyclodextrin-piroxicam in the treatment of acute pain from different rheumatic conditions
7. Total and free plasma and total synovial fluid piroxicam concentrations: Relationship to anti-inflammatory effect in patients with reactive arthritis and other arthritides
8. Detection of COX-1 and COX-2 isoforms in synovial fluid cells from inflammatory joint diseases
9. Pharmacokinetic quantification of the exchanges of drugs between blood and cerebrospinal fluid in man
10. Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid
11. Pharmacokinetics of oxicam non-steroidal anti-inflammatory agents
12. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam - β-cyclodextrin, piroxicam and placebo administration
13. Cyclodextrins. Properties and applications
14. Synovialgewebsspiegel in Vergleich zu Synovia und Serumkonzentrationen nach täglicher Einmalgabe von 20 mg Piroxicam (Felden)
15. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis